User menu

An Exploratory Study of Sunitinib (SU) Plus Docetaxel (D) and Trastuzumab (T) for First-Line Therapy of HER2+Advanced Breast Cancer (ABC).

Bibliographic reference Dirix, L. ; Machiels, Jean-Pascal ; Canon, Jean-Luc ; Amadori, D. ; Villa, E. ; et. al. An Exploratory Study of Sunitinib (SU) Plus Docetaxel (D) and Trastuzumab (T) for First-Line Therapy of HER2+Advanced Breast Cancer (ABC)..32nd Annual San Antonio Breast Cancer Symposium ((United-States) San Antonio, Texas, du 09/12/2009 au 13/12/2009). In: Cancer Research, Vol. 69, no. 24, p. 852S-853S (2009)
Permanent URL http://hdl.handle.net/2078.1/58648